Ex-10.1 Alkermes Amended Fiscal 2007 Named Executive Bonus Plan

EX-10.1 2 b62501aiexv10w1.htm EX-10.1 ALKERMES AMENDED FISCAL 2007 NAMED EXECUTIVE BONUS PLAN exv10w1
 

Exhibit 10.1
Adopted May 2, 2006 by the Compensation Committee
Amended September 21, 2006 by the Compensation Committee
Alkermes Amended Fiscal 2007 Named Executive Bonus Plan
The Alkermes Fiscal 2007 Named Executive Bonus Plan (the “Plan”) includes the following elements:
    Our Philosophy
    Eligibility
    Performance Period Company Objectives
    Size of Company Bonus Pool
    Individual Bonus Targets
    Individual Performance Factor
Our Philosophy
We believe in a pay-for performance approach that combines individual and Company performance with compensation to reward employees for the work they do to achieve Company goals. This Plan is designed to:
    provide upside reward for outstanding Company and individual performance
    motivate named executives to focus on and work together toward achieving Company and individual goals
    be competitive within our industry
Eligibility
Company named executives are eligible to participate in the plan. As of April 1, 2006, the following named executives have been approved for participation in the Plan:
    CEO
    President and COO
    Vice President and CFO
    Vice President Corporate Development
    Vice President, General Counsel and Secretary
As of September 21, 2006, the following executives have been approved for participation in the Plan as a result of their becoming named executive officers of the Company as of such date:
    Vice President, Science and Development and Chief Medical Officer
    Vice President, Operations
The performance period under the Plan will consist of the twelve month period from April 1, 2006 to March 31, 2007 (the “Performance Period”). Bonuses will be paid within two and one half months of the end of the period for which they are being paid.

 


 

Performance Period Company Objectives
The following are the overall Company objectives for the Performance Period:

Objective 1
Drive robust supply of Risperdal Consta sales

Objective 2
Launch and successfully commercialize Vivitrol™

Objective 3
Achieve key development program milestones

Objective 4
Financial performance against budget
The Compensation Committee of the Board of Directors reserves the right to modify the above objectives at any time during the course of the Performance Period in response to changing business goals, needs and operations.
Individual Bonus Targets
Individual bonus targets as a percentage of base salary are established by the Compensation Committee for each of the named executive officers. First year employees’ bonuses are to be prorated based on the number of days employed in the Performance Period both for purposes of determining the size of the bonus pool and individual bonus payments.
Size of Plan Bonus Pool
The Compensation Committee of the Board of Directors of the Company will determine the size of the overall bonus pool under all bonus plans of the Company based on Company performance against the above objectives and the target bonus figures. The size of the overall bonus pool shall be determined in the absolute discretion of the Compensation Committee.
Individual Performance Factor
Individual performance against individual objectives affects the bonus payout by increasing or decreasing by an individual performance factor the individual bonus targets. The precise individual performance factor for each employee eligible to receive a bonus under the Plan will be determined by the Compensation Committee of the Board of Directors of the Company. Individual bonus payouts will be determined in light of the overall bonus pool set by the Compensation Committee.